Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy

被引：149
|
作者：
Wilson, James M. [1 ]
Flotte, Terence R. [2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA 19104 USA
[2] Univ Massachusetts, Horae Gene Therapy Ctr, Med Sch, Worcester, MA 01605 USA
来源：
HUMAN GENE THERAPY | 2020年 / 31卷 / 13-14期
关键词：
D O I：
10.1089/hum.2020.182
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：695 / 696
页数：2
相关论文
共 50 条
  • [21] Moving forward: cystic fibrosis gene therapy
    Griesenbach, Uta
    Alton, Eric W. F. W.
    HUMAN MOLECULAR GENETICS, 2013, 22 : R52 - R58
  • [22] Gene and Cellular Therapy in Spain: Moving Forward
    Bosch, Fatima
    HUMAN GENE THERAPY, 2009, 20 (09) : 919 - 919
  • [23] Gene replacement therapy of myotubular myopathy: Restricting expression of MTM1 in skeletal muscle
    Buscara, L.
    Joubert, R.
    Moal, C.
    Poulard, K.
    Martin, S.
    Vignaud, A.
    Mavilio, F.
    Buj-Bello, A.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 807 - 808
  • [24] LONG-TERM EFFECTS OF SYSTEMIC GENE THERAPY ON GAIT IN A CANINE MODEL OF MYOTUBULAR MYOPATHY
    Pierson, Christopher R.
    MUSCLE & NERVE, 2017, 56 (05) : 839 - 840
  • [25] Gene Replacement Therapy of Myotubular Myopathy: Restricting Expression of MTM1 in Skeletal Muscle
    Buscara, Laurine
    Joubert, Romain
    Moal, Christel
    Poulard, Karine
    Martin, Samia
    Vignaud, Alban
    Mavilio, Fulvio
    Bello, Anna Buj
    MOLECULAR THERAPY, 2014, 22 : S295 - S295
  • [26] Aspiro Phase 1/2 Gene Therapy Trial in X-Linked Myotubular Myopathy (Xlmtm): Preliminary Safety and Efficacy Findings
    Kuntz, Nancy
    Shieh, Perry B.
    Smith, Barbara
    Bonnemann, Carsten G.
    Dowling, James J.
    Lawlor, Michael W.
    Mueller-Felber, Wolfgang
    Noursalehi, Mo
    Rico, Sal
    Servais, Laurent
    Prasad, Suyash
    MOLECULAR THERAPY, 2018, 26 (05) : 4 - 4
  • [27] Experiences of parents/caregivers of children in the ASPIRO X-Linked myotubular myopathy (XLMTM) gene therapy clinical trial: a qualitative study
    Juando-Prats, C.
    Hodwitz, K.
    Kenneally, N.
    Alfano, L.
    Sarazen, M.
    Coats, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S71 - S71
  • [28] An algorithm for discontinuing mechanical ventilation in boys with x-linked myotubular myopathy after positive response to gene therapy: the ASPIRO experience
    Graham, Robert J.
    Amin, Reshma
    Demirel, Nadir
    Edel, Lisa
    Lilien, Charlotte
    MacBean, Victoria
    Rafferty, Gerrard F.
    Sawnani, Hemant
    Schoen, Carola
    Smith, Barbara K.
    Syed, Faiza
    Sarazen, Micaela
    Prasad, Suyash
    Rico, Salvador
    Perez, Geovanny F.
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [29] ASPIRO Phase 1/2 Gene Therapy Trial In X-Linked Myotubular Myopathy (XLMTM): Update on Preliminary Safety and Efficacy Findings
    Shieh, Perry B.
    Kuntz, Nancy
    Smith, Barbara
    Bonnemann, Carsten G.
    Dowling, James J.
    Lawlor, Michael W.
    Mueller-Felber, Wolfgang
    Noursalehi, Mo
    Rico, Salvador
    Servais, Laurent
    Prasad, Suyash
    MOLECULAR THERAPY, 2019, 27 (04) : 306 - 306
  • [30] Systemic AAV8-MTM1 gene therapy for X-linked myotubular myopathy
    Mack, D. L.
    Poulard, K.
    Goddard, M.
    Snyder, J. M.
    Grange, R. W.
    Doering, J.
    Strande, J. L.
    Latournerie, V.
    Veron, P.
    Amor, F.
    Denard, J.
    Meng, H.
    Yang, L.
    Liu, F.
    Buscara, L.
    Le Bec, C.
    Martin, S.
    O'Callaghan, M.
    Mingozzi, F.
    Beggs, A. H.
    Lawlor, M. W.
    Mavilio, F.
    Mavilio, F.
    Childers, M. K.
    Bello, A. Buj
    HUMAN GENE THERAPY, 2015, 26 (10) : A73 - A74
12345